The University of Kansas Hospital
Kansas City, Kansas 66205
4 studies enrolling now · 27 studies all time
What they study most
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Aortic Valve Stenosis, BRAF V600E-mutant Metastatic Colorectal Cancer, Biochemical Recurrence of Malignant Neoplasm of Prostate, Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), Cancer of the Prostate, Carcinoma, Non-Small Cell Lung, Carcinoma, Non-Small-Cell Lung, Chronic Myeloid Leukemia
Studies at this site
- Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL — Recruiting now
- A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma — Recruiting now
- A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer — Recruiting now
- A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies — Recruiting now
- A Study of Sigvotatug Vedotin in Advanced Solid Tumors — Recruiting now
- A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies — Recruiting now
- Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer — Recruiting now
- Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK) — Running, not enrolling
- A Study of SGN-MesoC2 in Advanced Solid Tumors — Stopped early
- A Safety Study of PF-08046044/SGN-35C in Adults With Advanced Cancers — Stopped early
- Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies — Running, not enrolling
- Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients — Running, not enrolling
- A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms. — Stopped early
- Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer — Completed
- Study Evaluating SC262 in Subjects With r/r Non-Hodgkin's Lymphoma (VIVID) — Running, not enrolling
- Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy — Running, not enrolling
- A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) — Completed
- Use of NexoBrid for Treatment of Acute Deep Partial and Full Thickness Burn Injuries — APPROVED_FOR_MARKETING
- Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer — Completed
- A Study of CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate Cancer — Stopped early
- The Medtronic TAVR 2.0 US Clinical Study — Completed
- Predictive Assay for Decision Making in Adjuvant Therapy — Stopped early
- Standardized Treatment of Pulmonary Exacerbations II — Completed
- A Two-Part Multicenter Prospective Longitudinal Study of CFTR-dependent Disease Profiling in Cystic Fibrosis (PROSPECT) — Completed
- A Study to Assess the Safety and Efficacy of the of the Gastric-retentive AP-CD/LD in Advanced Parkinson's Patients — Status unconfirmed
- A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004 — Status unconfirmed
- EAP of CPX-351 (VYXEOS) for Patients 60-75 Years of Age With Secondary AML — APPROVED_FOR_MARKETING